|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 124.40 PLN | +1.47% |
|
+1.30% | -8.66% |
| 27/05 | Scope Fluidics says Bacteromic granted U.S. patent 'microfluidic chip' | RE |
| 15/05 | Scope Fluidics Q1 net loss at 13.5 million zlotys | RE |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
Compared values
| Sector | Change | 5-day change | YTD change | 1-year change | 5-year change | Capi. | ST | MT | LT | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| SCOPE FLUIDICS S.A. | Bio Diagnostics & Testing | +1.47% | +1.30% | -8.66% | -17.40% | -9.86% | 108M |  |  | |
- Stock Market
- Stocks
- SCP Stock
- Charts Scope Fluidics S.A.
- Comparison Chart
Select your edition
All financial news and data tailored to specific country editions
